The Comparison of Neutropenia and Peripheral Neuropathy Condition as an Impact of 3-hours and 24-hour Paclitaxel Infusion of Paclitaxel-Carboplatin Chemotherapy on Ovarian Cancer Patients
This study is aimed to compare the difference of neutropenia with peripheral neuropathy condition, after administration of 3 hours and 24 hours Paclitaxel infusion in adjuvant therapy with PaclitaxelCarboplatin toward patient with ovarian carcinoma. The method that used was experimental research wi...
Saved in:
Similar Items
-
KLK6 as a Predictor of Ovarian Malignancy
by: Primandono Perbowo, et al.
Published: (2019) -
RESPON KLINIS KEMOTERAPI PACLITAXEL CARBOPLATIN
PADA PENDERITA KANKER SERVIKS STADIUM IIB YANG
RESISTEN CISPLATIN DI RSUD Dr. SOETOMO TAHUN 2014-2015
by: dr. Hendra Moslem Nurdin
Published: (2017) -
Ekspresi Heat Shock Protein 70 (HSP70) dan Caspase-3 sebagai Prediktor terhadap Operabilitas Kanker Serviks Stadium IIB setelah Mendapat Kemoterapi Neoajuvant Paclitaxel-Carboplatin
by: Hermawan Udiyanto, -, et al.
Published: (2013) -
Disease-free survival and overall survival of cervical cancer patients after radical hysterectomy and pelvic lymph-node dissection
by: Brahmana Askandar, -, et al.
Published: (2020) -
The correlation of nutritional status with hematology toxicity of adjuvant chemotherapy in ovarian cancer
by: Kadek Dharma Widhiarta, -, et al.
Published: (2021)